Outcomes of Donation After Circulatory Death Lung Transplantation in the United States Based on Procurement Strategies: A United Network for Organ Sharing Analysis.
Ervin Y Cui, Doug A Gouchoe, Divyaam Satija, Martin G Walsh, Aaron Gou, Ammu V Alvarez, Matthew C Henn, Asvin M Ganapathi, Kukbin Choi, Bryan A Whitson
{"title":"Outcomes of Donation After Circulatory Death Lung Transplantation in the United States Based on Procurement Strategies: A United Network for Organ Sharing Analysis.","authors":"Ervin Y Cui, Doug A Gouchoe, Divyaam Satija, Martin G Walsh, Aaron Gou, Ammu V Alvarez, Matthew C Henn, Asvin M Ganapathi, Kukbin Choi, Bryan A Whitson","doi":"10.1097/TP.0000000000005803","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Donation after circulatory death (DCD) is increasingly utilized to expand the donor pool. Within DCD, direct procurement and perfusion (DPP) and thoracoabdominal normothermic regional perfusion (TA-NRP) have emerged as distinct procurement strategies. Yet, outcomes remain unclear especially in combination with ex vivo lung perfusion (EVLP).</p><p><strong>Methods: </strong>The United Network for Organ Sharing database was queried for adult lung transplants performed between December 2019 and March 2025. Recipients were stratified as donation after brain death (DBD), DCD DPP, or DCD TA-NRP. Propensity score matching was performed for DBD versus DCD, DBD versus DPP, DBD versus TA-NRP, and DPP versus TA-NRP comparisons. Additional analyses included DBD versus DCD EVLP subgroups. Outcomes included perioperative morbidity, primary graft dysfunction grade 3 (PGD3), and survival.</p><p><strong>Results: </strong>DCD recipients demonstrated increased perioperative morbidity including longer hospitalization (22 versus 19 d, P < 0.001), greater postoperative ECMO use (15.2% versus 8.1%, P < 0.001), and higher PGD3 incidence (25.6% versus 15.6%, P < 0.001) compared with DBD, though survival was similar ( P = 0.74). TA-NRP and DPP lungs had comparable outcomes, with TA-NRP showing slightly lower perioperative morbidity. Among EVLP recipients, DCD EVLP lungs were associated with longer hospitalization (26 versus 20 d, P < 0.001), higher ECMO use (19.2% versus 10.1%, P = 0.004), and a trend toward lower survival, though not statistically significant.</p><p><strong>Conclusions: </strong>DCD lungs yield survival comparable to DBD despite greater perioperative morbidity. NRP procurement may mitigate morbidity relative to DPP. Incorporating NRP into DCD practice may enhance lung utilization while maintaining acceptable outcomes.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e2122-e2134"},"PeriodicalIF":4.9000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/TP.0000000000005803","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Donation after circulatory death (DCD) is increasingly utilized to expand the donor pool. Within DCD, direct procurement and perfusion (DPP) and thoracoabdominal normothermic regional perfusion (TA-NRP) have emerged as distinct procurement strategies. Yet, outcomes remain unclear especially in combination with ex vivo lung perfusion (EVLP).
Methods: The United Network for Organ Sharing database was queried for adult lung transplants performed between December 2019 and March 2025. Recipients were stratified as donation after brain death (DBD), DCD DPP, or DCD TA-NRP. Propensity score matching was performed for DBD versus DCD, DBD versus DPP, DBD versus TA-NRP, and DPP versus TA-NRP comparisons. Additional analyses included DBD versus DCD EVLP subgroups. Outcomes included perioperative morbidity, primary graft dysfunction grade 3 (PGD3), and survival.
Results: DCD recipients demonstrated increased perioperative morbidity including longer hospitalization (22 versus 19 d, P < 0.001), greater postoperative ECMO use (15.2% versus 8.1%, P < 0.001), and higher PGD3 incidence (25.6% versus 15.6%, P < 0.001) compared with DBD, though survival was similar ( P = 0.74). TA-NRP and DPP lungs had comparable outcomes, with TA-NRP showing slightly lower perioperative morbidity. Among EVLP recipients, DCD EVLP lungs were associated with longer hospitalization (26 versus 20 d, P < 0.001), higher ECMO use (19.2% versus 10.1%, P = 0.004), and a trend toward lower survival, though not statistically significant.
Conclusions: DCD lungs yield survival comparable to DBD despite greater perioperative morbidity. NRP procurement may mitigate morbidity relative to DPP. Incorporating NRP into DCD practice may enhance lung utilization while maintaining acceptable outcomes.
期刊介绍:
The official journal of The Transplantation Society, and the International Liver Transplantation Society, Transplantation is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations per year.
Transplantation has been the trusted source for extensive and timely coverage of the most important advances in transplantation for over 50 years. The Editors and Editorial Board are an international group of research and clinical leaders that includes many pioneers of the field, representing a diverse range of areas of expertise. This capable editorial team provides thoughtful and thorough peer review, and delivers rapid, careful and insightful editorial evaluation of all manuscripts submitted to the journal.
Transplantation is committed to rapid review and publication. The journal remains competitive with a time to first decision of fewer than 21 days. Transplantation was the first in the field to offer CME credit to its peer reviewers for reviews completed.
The journal publishes original research articles in original clinical science and original basic science. Short reports bring attention to research at the forefront of the field. Other areas covered include cell therapy and islet transplantation, immunobiology and genomics, and xenotransplantation.